Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests

J. J.J.M. Stohr, V. F. Zwart, G. Goderski, A. Meijer, C. R.S. Nagel-Imming, M.F.Q. Kluytmans-van den Bergh, S. D. Pas, F. van den Oetelaar, M. Hellwich, K. H. Gan, A. Rietveld, J.J. Verweij, J. L. Murk, W. van den Bijllaardt, J. A. J. W. Kluytmans
doi: https://doi.org/10.1101/2021.02.21.21252153
J. J.J.M. Stohr
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joep.stohr@gmail.com
V. F. Zwart
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Goderski
4National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Meijer
4National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. R.S. Nagel-Imming
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.F.Q. Kluytmans-van den Bergh
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
5Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. D. Pas
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. van den Oetelaar
7Municipal Health Services GGD Hart voor Brabant, ‘s-Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Hellwich
7Municipal Health Services GGD Hart voor Brabant, ‘s-Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. H. Gan
7Municipal Health Services GGD Hart voor Brabant, ‘s-Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Rietveld
7Municipal Health Services GGD Hart voor Brabant, ‘s-Hertogenbosch, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.J. Verweij
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. L. Murk
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. van den Bijllaardt
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. A. J. W. Kluytmans
1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
5Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Self-testing for COVID-19 infection with lateral flow assay SARS-CoV-2 rapid antigen detection tests (RDT), provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2. The objective of this study is to evaluate the performance of self-testing using RDT without assistance.

Methods Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD RDT) or Roche SARS-CoV-2 antigen detection test (Roche RDT). Oro-nasopharyngeal swabs were collected from the participants for qRT-PCR testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture was dropping below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined.

Results A total of 3,215 participants were included (BD RDT n=1604; Roche RDT n=1611). Sensitivity and specificity of self-testing compared to the qRT-PCR results with Ct-value below the Ct-value cut-off was 78.0% (95% CI:72.5-82.8) and 99.4% (95%CI: 99.0-99.6) respectively. Determinants independently associated with a false-negative self-testing results were: higher age, low viral load and finding self-testing difficult.

Discussion Self-testing using currently available RDT’s has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness. The performance of two tests were comparable. This application has the potential for frequent and extensive testing which may be an aid to lift restrictions to society while controlling the spread of SARS-CoV-2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded by the Dutch ministry of health, welfare and sports (VWS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was reviewed by the Dutch Medical research Ethics Committees United (MEC-U). The study was judged to be beyond the scope of the Dutch medical scientific research act (WMO).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data has been included in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests
J. J.J.M. Stohr, V. F. Zwart, G. Goderski, A. Meijer, C. R.S. Nagel-Imming, M.F.Q. Kluytmans-van den Bergh, S. D. Pas, F. van den Oetelaar, M. Hellwich, K. H. Gan, A. Rietveld, J.J. Verweij, J. L. Murk, W. van den Bijllaardt, J. A. J. W. Kluytmans
medRxiv 2021.02.21.21252153; doi: https://doi.org/10.1101/2021.02.21.21252153
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests
J. J.J.M. Stohr, V. F. Zwart, G. Goderski, A. Meijer, C. R.S. Nagel-Imming, M.F.Q. Kluytmans-van den Bergh, S. D. Pas, F. van den Oetelaar, M. Hellwich, K. H. Gan, A. Rietveld, J.J. Verweij, J. L. Murk, W. van den Bijllaardt, J. A. J. W. Kluytmans
medRxiv 2021.02.21.21252153; doi: https://doi.org/10.1101/2021.02.21.21252153

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8987)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1959)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10809)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1903)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)